Table 1.
Cohort demographics.
| Characteristic | Infection-only (n) | Hybrid-immunity (n) | ||
|---|---|---|---|---|
| One dose | Two doses | Three doses | ||
| Donors | 47 | 105 | 160 | 136 |
| Sex | ||||
| Male | 30 | 64 | 86 | 71 |
| Female | 17 | 41 | 74 | 65 |
| Age, years (mean ± SD) | 39.38 ± 8.12 | 40.48 ± 7.55 | 40.24 ± 8.62 | 41.98 ± 8.00 |
| Months post vaccinationa | ||||
| 1–3 | NA | 6 | 28 | 130 |
| 4–6 | NA | 32 | 78 | 6 |
| 7–9 | NA | 56 | 51 | 0 |
| 10–12 | NA | 11 | 3 | 0 |
| Disease severity | ||||
| Asymptomatic | 1 | 8 | 16 | 9 |
| Mild | 18 | 46 | 74 | 63 |
| Moderate | 21 | 43 | 59 | 53 |
| Severe | 7 | 7 | 11 | 9 |
| Critical | 0 | 1 | 0 | 2 |
NA not applicable.
aMonths were calculated after the final dose of vaccination.